207 related articles for article (PubMed ID: 15244191)
41. Extragastrointestinal stromal tumors presenting as vulvovaginal/rectovaginal septal masses: a diagnostic pitfall.
Lam MM; Corless CL; Goldblum JR; Heinrich MC; Downs-Kelly E; Rubin BP
Int J Gynecol Pathol; 2006 Jul; 25(3):288-92. PubMed ID: 16810068
[TBL] [Abstract][Full Text] [Related]
42. Plexiform fibromyxoma: a distinctive benign gastric antral neoplasm not to be confused with a myxoid GIST.
Miettinen M; Makhlouf HR; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Nov; 33(11):1624-32. PubMed ID: 19675452
[TBL] [Abstract][Full Text] [Related]
43. Mucosal Schwann cell "hamartoma": clinicopathologic study of 26 neural colorectal polyps distinct from neurofibromas and mucosal neuromas.
Gibson JA; Hornick JL
Am J Surg Pathol; 2009 May; 33(5):781-7. PubMed ID: 19065103
[TBL] [Abstract][Full Text] [Related]
44. Expression of COX-2, PCNA, Ki-67 and p53 in gastrointestinal stromal tumors and its relationship with histopathological parameters.
Gumurdulu D; Erdogan S; Kayaselcuk F; Seydaoglu G; Parsak CK; Demircan O; Tuncer I
World J Gastroenterol; 2007 Jan; 13(3):426-31. PubMed ID: 17230613
[TBL] [Abstract][Full Text] [Related]
45. [Intra-abdomen extragastrointestinal stromal tumors: a clinicopathologic study on 30 cases].
Shao YF; Bai YK; Cao WL; Shi SS; Gao YN; Sun YT; Yu LW
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):29-32. PubMed ID: 17253169
[TBL] [Abstract][Full Text] [Related]
46. Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha/beta), c-met, and EGFR.
Schirosi L; Lantuejoul S; Cavazza A; Murer B; Yves Brichon P; Migaldi M; Sartori G; Sgambato A; Rossi G
Am J Surg Pathol; 2008 Nov; 32(11):1627-42. PubMed ID: 18753943
[TBL] [Abstract][Full Text] [Related]
47. Synchronous gastrointestinal stromal tumors (GIST) and other primary cancers: case series of a single institution experience.
Ferreira SS; Werutsky G; Toneto MG; Alves JM; Piantá CD; Breunig RC; Brondani da Rocha A; Grivicich I; Garicochea B
Int J Surg; 2010; 8(4):314-7. PubMed ID: 20380900
[TBL] [Abstract][Full Text] [Related]
48. Gastrointestinal stromal tumor and gastric adenocarcinoma collision tumors.
Kleist B; Lasota J; Miettinen M
Hum Pathol; 2010 Jul; 41(7):1034-9. PubMed ID: 20381123
[TBL] [Abstract][Full Text] [Related]
49. Stromal expression of actin is a marker of aggressiveness in basal cell carcinoma.
Adegboyega PA; Rodriguez S; McLarty J
Hum Pathol; 2010 Aug; 41(8):1128-37. PubMed ID: 20381122
[TBL] [Abstract][Full Text] [Related]
50. Comparison of tissue microarray and full section in immunohistochemistry of gastrointestinal stromal tumors.
Kwon MJ; Nam ES; Cho SJ; Park HR; Shin HS; Park JH; Park CH; Lee WJ
Pathol Int; 2009 Dec; 59(12):851-6. PubMed ID: 20021609
[TBL] [Abstract][Full Text] [Related]
51. Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors.
Sabattini S; Bettini G
Vet Pathol; 2010 Jul; 47(4):643-53. PubMed ID: 20418469
[TBL] [Abstract][Full Text] [Related]
52. Nuclear morphometric analysis in gastrointestinal stromal tumors: a preliminary study.
Ozdamar SO; Bektaş S; Erdem Ozdamar S; Gedikoğlu G; Doğan Gün B; Bahadir B
Turk J Gastroenterol; 2007 Jun; 18(2):71-6. PubMed ID: 17602353
[TBL] [Abstract][Full Text] [Related]
53. Colorectal granular cell tumor: a clinicopathologic study of 26 cases.
Singhi AD; Montgomery EA
Am J Surg Pathol; 2010 Aug; 34(8):1186-92. PubMed ID: 20661017
[TBL] [Abstract][Full Text] [Related]
54. Clinicopathologic analysis of 4 perivascular epithelioid cell tumors (PEComas) of the gastrointestinal tract.
Shi HY; Wei LX; Sun L; Guo AT
Int J Surg Pathol; 2010 Aug; 18(4):243-7. PubMed ID: 19124450
[TBL] [Abstract][Full Text] [Related]
55. [Imaging and pathological features of gastrointestinal stromal tumors].
Song T; Shen J; Guo HC; Liang BL; Pan H; Jiang KM; Xian JX
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):386-90. PubMed ID: 17892139
[TBL] [Abstract][Full Text] [Related]
56. Prediction of KIT mutation in gastrointestinal stromal tumors by the immunoprofile of the tumor cells.
Chou CC; Chou MJ; Tzen CY
J Formos Med Assoc; 2010 Jan; 109(1):25-31. PubMed ID: 20123583
[TBL] [Abstract][Full Text] [Related]
57. Protein S100 as prognostic marker for gastrointestinal stromal tumors: a clinicopathological risk factor analysis.
Perez D; Demartines N; Meier K; Clavien PA; Jungbluth A; Jaeger D
J Invest Surg; 2007; 20(3):181-6. PubMed ID: 17613693
[TBL] [Abstract][Full Text] [Related]
58. KIT-negative gastrointestinal stromal tumors with a long term follow-up: a new subgroup does exist.
Kontogianni-Katsarou K; Lariou C; Tsompanaki E; Vourlakou C; Kairi-Vassilatou E; Mastoris C; Pantazi G; Kondi-Pafiti A
World J Gastroenterol; 2007 Feb; 13(7):1098-102. PubMed ID: 17373746
[TBL] [Abstract][Full Text] [Related]
59. Immunohistochemical expression of Ki67, c-erbB-2, and c-kit antigens in benign and malignant pheochromocytoma.
Tavangar SM; Shojaee A; Moradi Tabriz H; Haghpanah V; Larijani B; Heshmat R; Lashkari A; Azimi S
Pathol Res Pract; 2010 May; 206(5):305-9. PubMed ID: 20189725
[TBL] [Abstract][Full Text] [Related]
60. Esophageal mesenchymal tumors: endoscopy, pathology and immunohistochemistry.
Zhu X; Zhang XQ; Li BM; Xu P; Zhang KH; Chen J
World J Gastroenterol; 2007 Feb; 13(5):768-73. PubMed ID: 17278201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
